SS
REGN icon

Sunbelt Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Sunbelt Securities’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.4K Hold
16
– – ﹤0.01% 1443
2025
Q4 		$12.4K Buy
16
+2
+14% +$1.36K ﹤0.01% 1390
2025
Q3 		$7.88K Sell
14
-23
-62% -$13K ﹤0.01% 1503
2025
Q2 		$26.4K Buy
37
+7
+23% +$3.91K ﹤0.01% 1098
2025
Q1 		$18.7K Sell
30
-10
-25% -$6.88K ﹤0.01% 1134
2024
Q4 		$28.1K Hold
40
– – ﹤0.01% 1081
2024
Q3 		$42K Buy
40
+3
+8% +$3.34K ﹤0.01% 985
2024
Q2 		$38.9K Hold
37
– – ﹤0.01% 970
2024
Q1 		$35.6K Hold
37
– – ﹤0.01% 951
2023
Q4 		$32.5K Buy
37
+3
+9% +$2.47K ﹤0.01% 904
2023
Q3 		$28K Buy
34
+3
+10% +$2.36K ﹤0.01% 933
2023
Q2 		$22.3K Hold
31
– – ﹤0.01% 997
2023
Q1 		$25.2K Buy
+31
New +$23.4K ﹤0.01% 894

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sunbelt Securities's REGN Position: Q1 2026 in Review

Sunbelt Securities held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 16 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1443.

Sunbelt Securities first reported a position in REGN in Q1 2023 and has held it in 13 quarters since. The position peaked at $42K in Q3 2024. 1,400 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Sunbelt Securities held 16 shares of Regeneron Pharmaceuticals worth $12.4K as of Q1 2026.
  • Sunbelt Securities left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1443 holding.
  • Sunbelt Securities first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
  • Sunbelt Securities's Regeneron Pharmaceuticals position peaked at $42K in Q3 2024.
  • 1,400 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.